跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Heme D
首页
药物
Heme D
Experimental
Small Molecule
Heme D
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
34
H
32
FeN
4
O
10
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method for increasing intracellular heme content of Escherichia coli
申请人: UNIV JIANGNAN
优先权: 2020
CN
US
2 件公开
Screening method for identifying heme independent modulators of soluble guanylyl cyclase (sGC) activity using alphabetaCys105 mutant sGC
申请人: UNIV TEXAS
优先权: 2004
US
Polypeptide composition for improving anemia symptoms and preparation method thereof
申请人: HANGZHOU BAIBEI BIOLOGICAL TECH CO LTD
优先权: 2021
CN
Composition containing aloe arborescens and application
申请人: GUANGDONG ALOE COSMETIC CO LTD
优先权: 2022
CN
Composition containing aloe active compound and preparation method and application thereof
申请人: ZHENGZHOU KELLI BIOTECHNOLOGY CO LTD
优先权: 2022
CN
BACTERIAL LACTOPEROXIDASES AND PRODUCTS AND METHODS RELATED THERETO.
申请人: GECCO BIOTECH B V
优先权: 2024
WO
Fusion vitamin D hydroxylase and application thereof in preparation of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
申请人: UNIV SICHUAN
优先权: 2026
CN
药物
反馈